Shephard Mpofu
Chief Tech/Sci/R&D Officer at ACELYRIN, INC.
Profile
Shephard Mpofu is currently working as the Chief Medical Officer at ACELYRIN, Inc. since 2024.
Previously, he worked at Novartis Gene Therapies, Inc. as the Chief Medical Officer & Senior Vice President.
Dr. Mpofu completed his undergraduate degree at the University of Zimbabwe.
Shephard Mpofu active positions
Companies | Position | Start |
---|---|---|
ACELYRIN, INC. | Chief Tech/Sci/R&D Officer | 2024-05-08 |
Former positions of Shephard Mpofu
Companies | Position | End |
---|---|---|
AVEXIS INC | Chief Tech/Sci/R&D Officer | - |
Training of Shephard Mpofu
University of Zimbabwe | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ACELYRIN, INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Shephard Mpofu